These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24748145)

  • 21. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.
    Zhou C; Zhang Z; Zhu X; Qian G; Zhou Y; Sun Y; Yu W; Wang J; Lu H; Lin F; Shen Z; Zheng S
    EBioMedicine; 2020 Sep; 59():102955. PubMed ID: 32853985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
    Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
    Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.
    Hedley BD; Vaidya KS; Phadke P; MacKenzie L; Dales DW; Postenka CO; MacDonald IC; Chambers AF
    Clin Exp Metastasis; 2008; 25(7):727-40. PubMed ID: 18543067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress on breast cancer metastasis suppressor 1 (BRMS1)].
    Yuan Y; Zhu ZY; Lai ZC; Zhang WX
    Yi Chuan; 2006 Sep; 28(9):1141-8. PubMed ID: 16963426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
    DeWald DB; Torabinejad J; Samant RS; Johnston D; Erin N; Shope JC; Xie Y; Welch DR
    Cancer Res; 2005 Feb; 65(3):713-7. PubMed ID: 15705865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer metastasis suppressor gene, breast cancer metastasis suppressor 1, may be associated with clinicopathological features of breast cancer.
    Lin L; Cai M; Dai Y; Zheng Z; Jiang F; Shi L; Pan Y; Song HB
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S368-S374. PubMed ID: 29970691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Metastasis Suppressor 1 (BRMS1): Robust Biological and Pathological Data, But Still Enigmatic Mechanism of Action.
    Welch DR; Manton CA; Hurst DR
    Adv Cancer Res; 2016; 132():111-37. PubMed ID: 27613131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
    Liu HY; Zhou B; Wang L; Li Y; Zhou ZG; Sun XF; Xu B; Zeng YJ; Song JM; Luo HZ; Yang L
    Oncology; 2007; 73(5-6):384-8. PubMed ID: 18511876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cdk2 regulates metastasis suppressor BRMS1.
    Caldon CE
    Cell Cycle; 2016; 15(6):779-80. PubMed ID: 26730572
    [No Abstract]   [Full Text] [Related]  

  • 30. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
    Silveira AC; Hurst DR; Vaidya KS; Ayer DE; Welch DR
    Cancer Lett; 2009 Apr; 276(1):32-7. PubMed ID: 19070953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterisation of the breast cancer metastasis suppressor, BRMS1.
    Smith J; Naseem R; Webb M
    Protein Expr Purif; 2009 Oct; 67(2):70-5. PubMed ID: 19401233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B.
    Peng H; Luo J; Hao H; Hu J; Xie SK; Ren D; Rao B
    Oncol Rep; 2014 May; 31(5):2055-62. PubMed ID: 24626817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.
    Roesley SN; Suryadinata R; Morrish E; Tan AR; Issa SM; Oakhill JS; Bernard O; Welch DR; Šarčević B
    Cell Cycle; 2016; 15(1):137-51. PubMed ID: 26771717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor.
    Rivera J; Megías D; Navas C; Bravo J
    PLoS One; 2009 Jul; 4(7):e6433. PubMed ID: 19649328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.
    Chen X; Scapa JE; Liu DX; Godbey WT
    J Gene Med; 2016 Jul; 18(7):89-101. PubMed ID: 27140445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
    Rivera J; Megias D; Bravo J
    J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA expression of the putative antimetastatic gene BRMS1 and of apoptosis-related genes in breast cancer.
    Schneider J; Gómez-Esquer F; Díaz-Gil G; Torrejón R; Pollán M
    Cancer Genomics Proteomics; 2011; 8(4):195-7. PubMed ID: 21737612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.